
Breaking Records: Tevogen Bio Specialty Care Projects Nearly $1 Billion in Top-Line Revenue for Launch Year and $18-22 Billion in 5-Year Estimate
Tevogen Bio Announces Impressive Revenue Forecast Introduction In a recent announcement, Tevogen Bio revealed its top-line revenue forecast for its specialty care pipeline, projecting a substantial influx of nearly $1 billion in revenue in its launch year. The company also anticipates a cumulative estimate of between $18 billion and $22 billion over the next 5…